Ignite Creation Date:
2025-12-24 @ 2:59 PM
Ignite Modification Date:
2026-02-28 @ 10:10 AM
Study NCT ID:
NCT05399459
Status:
COMPLETED
Last Update Posted:
2025-03-07
First Post:
2022-05-27
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety Study of Rimegepant for the Acute Treatment of Migraine in Japanese Subjects (Japan Only)
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-08-09
Start Date Type:
ACTUAL
Primary Completion Date:
2024-01-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-01-19
Completion Date Type:
ACTUAL
First Submit Date:
2022-05-27
First Submit QC Date:
None
Study First Post Date:
2022-06-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-01-14
Results First Submit QC Date:
None
Results First Post Date:
2025-02-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-04
Last Update Post Date:
2025-03-07
Last Update Post Date Type:
ACTUAL